These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 24553139)

  • 1. Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2.
    Khan AG; Whidby J; Miller MT; Scarborough H; Zatorski AV; Cygan A; Price AA; Yost SA; Bohannon CD; Jacob J; Grakoui A; Marcotrigiano J
    Nature; 2014 May; 509(7500):381-4. PubMed ID: 24553139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational Flexibility in the Immunoglobulin-Like Domain of the Hepatitis C Virus Glycoprotein E2.
    Vasiliauskaite I; Owsianka A; England P; Khan AG; Cole S; Bankwitz D; Foung SKH; Pietschmann T; Marcotrigiano J; Rey FA; Patel AH; Krey T
    mBio; 2017 May; 8(3):. PubMed ID: 28512091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus E2 envelope glycoprotein core structure.
    Kong L; Giang E; Nieusma T; Kadam RU; Cogburn KE; Hua Y; Dai X; Stanfield RL; Burton DR; Ward AB; Wilson IA; Law M
    Science; 2013 Nov; 342(6162):1090-4. PubMed ID: 24288331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Optimized Hepatitis C Virus E2 Glycoprotein Core Adopts a Functional Homodimer That Efficiently Blocks Virus Entry.
    McCaffrey K; Boo I; Owczarek CM; Hardy MP; Perugini MA; Fabri L; Scotney P; Poumbourios P; Drummer HE
    J Virol; 2017 Mar; 91(5):. PubMed ID: 28031364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C Virus Structure: Defined by What It Is Not.
    Dearborn AD; Marcotrigiano J
    Cold Spring Harb Perspect Med; 2020 Jan; 10(1):. PubMed ID: 31501263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unexpected structural features of the hepatitis C virus envelope protein 2 ectodomain.
    Sabahi A; Uprichard SL; Wimley WC; Dash S; Garry RF
    J Virol; 2014 Sep; 88(18):10280-8. PubMed ID: 24991010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1.
    Johnson J; Freedman H; Logan M; Wong JAJ; Hockman D; Chen C; He J; Beard MR; Eyre NS; Baumert TF; Tyrrell DL; Law JLM; Houghton M
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural insights into hepatitis C virus receptor binding and entry.
    Kumar A; Hossain RA; Yost SA; Bu W; Wang Y; Dearborn AD; Grakoui A; Cohen JI; Marcotrigiano J
    Nature; 2021 Oct; 598(7881):521-525. PubMed ID: 34526719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional Study of the C-Terminal Part of the Hepatitis C Virus E1 Ectodomain.
    Moustafa RI; Haddad JG; Linna L; Hanoulle X; Descamps V; Mesalam AA; Baumert TF; Duverlie G; Meuleman P; Dubuisson J; Lavie M
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30068644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of conserved residues in hepatitis C virus envelope glycoprotein E2 that modulate virus dependence on CD81 and SRB1 entry factors.
    Lavie M; Sarrazin S; Montserret R; Descamps V; Baumert TF; Duverlie G; Séron K; Penin F; Dubuisson J
    J Virol; 2014 Sep; 88(18):10584-97. PubMed ID: 24990994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural changes of envelope proteins during alphavirus fusion.
    Li L; Jose J; Xiang Y; Kuhn RJ; Rossmann MG
    Nature; 2010 Dec; 468(7324):705-8. PubMed ID: 21124457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unexpected structure for the N-terminal domain of hepatitis C virus envelope glycoprotein E1.
    El Omari K; Iourin O; Kadlec J; Sutton G; Harlos K; Grimes JM; Stuart DI
    Nat Commun; 2014 Sep; 5():4874. PubMed ID: 25224686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Novel Functions for Hepatitis C Virus Envelope Glycoprotein E1 in Virus Entry and Assembly.
    Haddad JG; Rouillé Y; Hanoulle X; Descamps V; Hamze M; Dabboussi F; Baumert TF; Duverlie G; Lavie M; Dubuisson J
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28179528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C Virus Envelope Glycoprotein E1 Forms Trimers at the Surface of the Virion.
    Falson P; Bartosch B; Alsaleh K; Tews BA; Loquet A; Ciczora Y; Riva L; Montigny C; Montpellier C; Duverlie G; Pécheur EI; le Maire M; Cosset FL; Dubuisson J; Penin F
    J Virol; 2015 Oct; 89(20):10333-46. PubMed ID: 26246575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus-Like Particles Containing the E2 Core Domain of Hepatitis C Virus Generate Broadly Neutralizing Antibodies in Guinea Pigs.
    McGregor J; Hardy JM; Lay CS; Boo I; Piontek M; Suckow M; Coulibaly F; Poumbourios P; Center RJ; Drummer HE
    J Virol; 2022 Mar; 96(5):e0167521. PubMed ID: 34986001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct roles in folding, CD81 receptor binding and viral entry for conserved histidine residues of hepatitis C virus glycoprotein E1 and E2.
    Boo I; teWierik K; Douam F; Lavillette D; Poumbourios P; Drummer HE
    Biochem J; 2012 Apr; 443(1):85-94. PubMed ID: 22240035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hepatitis C virus envelope protein complex is a dimer of heterodimers.
    Augestad EH; Holmboe Olesen C; Grønberg C; Soerensen A; Velázquez-Moctezuma R; Fanalista M; Bukh J; Wang K; Gourdon P; Prentoe J
    Nature; 2024 Sep; 633(8030):704-709. PubMed ID: 39232163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical interaction between E1 and E2 glycoproteins determines binding and fusion properties of hepatitis C virus during cell entry.
    Douam F; Dao Thi VL; Maurin G; Fresquet J; Mompelat D; Zeisel MB; Baumert TF; Cosset FL; Lavillette D
    Hepatology; 2014 Mar; 59(3):776-88. PubMed ID: 24038151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Conserved E2 Residue W420 in Receptor Binding and Hepatitis C Virus Infection.
    Cowton VM; Angus AGN; Cole SJ; Markopoulou CK; Owsianka A; Dunlop JI; Gardner DE; Krey T; Patel AH
    J Virol; 2016 Aug; 90(16):7456-7468. PubMed ID: 27279607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HCV Broadly Neutralizing Antibodies Use a CDRH3 Disulfide Motif to Recognize an E2 Glycoprotein Site that Can Be Targeted for Vaccine Design.
    Flyak AI; Ruiz S; Colbert MD; Luong T; Crowe JE; Bailey JR; Bjorkman PJ
    Cell Host Microbe; 2018 Nov; 24(5):703-716.e3. PubMed ID: 30439340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.